A subsequent work confirmed these observations using CRC cell lines and spheroids, reporting that targeting DOT1L by miR-133b reduces CRC cell chemoresistance and stemness by suppression of H3K79 di-methylation of stem cells genes (Lv et al., 2019). Here, DOT1L is linked to colorectal carcinoma.